Literature DB >> 8458977

Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients.

F Barbut1, C Depitre, M Delmée, G Corthier, J C Petit.   

Abstract

We analyzed and compared Clostridium difficile strains isolated from diarrheic stools of 49 human immunodeficiency virus (HIV)-negative and 50 AIDS patients. Our results suggest that distribution patterns of serogroups are different in these two populations. Serogroup C (which has been previously reported to be very resistant to antimicrobial agents) represents 66.0 and 18.4% of the isolates from AIDS and HIV-negative patients, respectively (P < 0.001); the selection of serogroup C could be explained by multiple antibiotic pressure to which AIDS patients have been subjected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458977      PMCID: PMC262860          DOI: 10.1128/jcm.31.3.740-742.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile.

Authors:  M Delmée; V Avesani
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

2.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

3.  Clostridium difficile in neonates: serogrouping and epidemiology.

Authors:  M Delmée; G Verellen; V Avesani; G Francois
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

4.  Epidemiology and prevention of Clostridium difficile infections in a leukemia unit.

Authors:  M Delmée; B Vandercam; V Avesani; J L Michaux
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

5.  The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients.

Authors:  S R Heard; S O'Farrell; D Holland; S Crook; M J Barnett; S Tabaqchali
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

Review 6.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 7.  Epidemiologic markers of Clostridium difficile.

Authors:  S Tabaqchali
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

8.  Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.

Authors:  G Corthier; M C Muller; T D Wilkins; D Lyerly; R L'Haridon
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.

Authors:  S H Willey; J G Bartlett
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

10.  Serogrouping of Clostridium difficile strains by slide agglutination.

Authors:  M Delmee; M Homel; G Wauters
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

View more
  5 in total

1.  Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection.

Authors:  D N Shah; N S Bhatt; J K Welch; H L Koo; K W Garey
Journal:  J Hosp Infect       Date:  2013-02-20       Impact factor: 3.926

2.  Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C.

Authors:  P van Dijck; V Avesani; M Delmée
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

3.  Norovirus infection as a cause of sporadic healthcare-associated diarrhoea.

Authors:  H L Koo; N J Ajami; Z-D Jiang; R L Atmar; H L DuPont
Journal:  J Hosp Infect       Date:  2009-04-19       Impact factor: 3.926

4.  Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital.

Authors:  Miguel Salazar; Kevin W Garey; Zhi-Dong Jiang; Thanh Dao-Tran; Herbert DuPont
Journal:  Pharm World Sci       Date:  2009-08-06

Review 5.  Diagnosis and treatment of colonic disease in AIDS.

Authors:  K E Mönkemüller; C M Wilcox
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.